PROVECTUS BIOPHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Provectus Biopharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.01M, a 30.7% decline year-over-year.
  • Provectus Biopharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.03M, a 4.49% increase year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.1M, a 12.7% increase from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.55M, a 35.8% increase from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$5.54M, a 17% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.1M +$453K +12.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$3.55M +$1.98M +35.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$5.54M +$1.14M +17% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$6.68M +$245K +3.54% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$6.92M +$1.23M +15.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$8.15M +$5.36M +39.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$13.5M +$10.9M +44.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$24.4M +$75.1K +0.31% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 -$24.5M -$14.3M -139% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$10.2M +$17.5M +63% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-31
2013 -$27.7M -$15.1M -120% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
2012 -$12.6M +$6.87M +35.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$19.4M -$883K -4.76% Jan 1, 2011 Dec 31, 2011 10-Q 2014-08-07
2010 -$18.6M Jan 1, 2010 Dec 31, 2010 10-Q 2014-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.